Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.

Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A.

BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28.

2.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

3.

Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.

Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, Martin X, Gelet A.

Eur Urol. 2014 May;65(5):907-14. doi: 10.1016/j.eururo.2013.04.039. Epub 2013 Apr 30.

PMID:
23669165
4.

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.

Pinthus JH, Farrokhyar F, Hassouna MM, Woods E, Whelan K, Shayegan B, Orovan WL.

BJU Int. 2012 Oct;110(8):1142-8. doi: 10.1111/j.1464-410X.2012.10945.x. Epub 2012 Feb 28.

5.

Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.

Thüroff S, Chaussy C.

J Urol. 2013 Aug;190(2):702-10. doi: 10.1016/j.juro.2013.02.010. Epub 2013 Feb 13.

PMID:
23415962
6.

High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

Challacombe BJ, Murphy DG, Zakri R, Cahill DJ.

BJU Int. 2009 Jul;104(2):200-4. doi: 10.1111/j.1464-410X.2009.08355.x. Epub 2009 Feb 11.

7.

High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.

Cordeiro ER, Cathelineau X, Thüroff S, Marberger M, Crouzet S, de la Rosette JJ.

BJU Int. 2012 Nov;110(9):1228-42. doi: 10.1111/j.1464-410X.2012.11262.x. Epub 2012 Jun 6. Review.

8.

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

Inoue Y, Goto K, Hayashi T, Hayashi M.

Int J Urol. 2011 May;18(5):358-62. doi: 10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

9.

Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.

Crouzet S, Murat FJ, Pommier P, Poissonnier L, Pasticier G, Rouviere O, Chapelon JY, Rabilloud M, Belot A, Mège-Lechevallier F, Tonoli-Catez H, Martin X, Gelet A.

Radiother Oncol. 2012 Nov;105(2):198-202. doi: 10.1016/j.radonc.2012.09.014. Epub 2012 Oct 12.

PMID:
23068708
10.

[High-intensity focussed ultrasound in low-risk prostate cancer - oncological outcome and postinterventional quality of life of an inexperienced therapy centre in comparison with an experienced therapy centre].

Baumunk D, Andersen C, Heile U, Ebbing J, Cash H, Porsch M, Liehr UB, Janitzky A, Wendler JJ, Schindele D, Blaschke S, Miller K, Schostak M.

Aktuelle Urol. 2013 Jul;44(4):285-92. doi: 10.1055/s-0033-1348253. Epub 2013 Jul 25. German.

PMID:
23888408
11.

Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.

Boutier R, Girouin N, Cheikh AB, Belot A, Rabilloud M, Gelet A, Chapelon JY, Rouvière O.

BJU Int. 2011 Dec;108(11):1776-81. doi: 10.1111/j.1464-410X.2011.10251.x. Epub 2011 Jun 28.

12.
13.

Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB.

BJU Int. 2014 Oct;114(4):532-40. doi: 10.1111/bju.12545. Epub 2014 Apr 16.

14.

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon JY, Gelet A.

Eur Urol. 2009 Mar;55(3):640-7. doi: 10.1016/j.eururo.2008.04.091. Epub 2008 May 9.

PMID:
18508188
15.

Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment.

Munoz F, Guarneri A, Botticella A, Gabriele P, Moretto F, Panaia R, Ruggieri A, D'Urso L, Muto G, Filippi AR, Ragona R, Ricardi U.

Urol Int. 2013;90(3):288-93. doi: 10.1159/000345631. Epub 2013 Jan 30.

PMID:
23364287
16.

High-intensity focused ultrasound therapy for clinically localized prostate cancer.

Lee HM, Hong JH, Choi HY.

Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18.

PMID:
16847468
17.

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

Blana A, Walter B, Rogenhofer S, Wieland WF.

Urology. 2004 Feb;63(2):297-300. Review.

PMID:
14972475
18.

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.

Rebillard X, Soulié M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL, Coulange C; Association Francaise d'Urologie..

BJU Int. 2008 May;101(10):1205-13. doi: 10.1111/j.1464-410X.2008.07504.x. Epub 2008 Mar 4. Review.

19.

Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.

Elterman DS, Barkin J, Radomski SB, Fleshner NE, Liu B, Bensimon K, Arora S, Robinette M, Finelli A.

Can J Urol. 2011 Dec;18(6):6037-42.

PMID:
22166332
20.

Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer.

Misraï V, Rouprêt M, Chartier-Kastler E, Comperat E, Renard-Penna R, Haertig A, Bitker MO, Richard F, Conort P.

World J Urol. 2008 Oct;26(5):481-5. doi: 10.1007/s00345-008-0286-8. Epub 2008 Jun 26.

PMID:
18581118

Supplemental Content

Support Center